Alex Goldberg

NASDAQ Gainers Watch List: Coronado Biosciences, Inc. (NASDAQ:CNDO) and Windstream Holdings, Inc. (NASDAQ:WIN) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/26/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Coronado Biosciences, Inc. (NASDAQ:CNDO) and Windstream Holdings, Inc. (NASDAQ:WIN).

Coronado Biosciences, Inc. (NASDAQ:CNDO) a clinical stage biopharmaceutical company that focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer is currently up (+4.16%) on 1,364,701 shares traded after CORONADO BIOSCIENCES INC Filed SEC form 8-K, Other Events, Financial Statements and Exhibits. Coronado Biosciences, Inc. (NASDAQ:CNDO) is currently up (+105.6%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Coronado Biosciences, Inc. (NASDAQ:CNDO)

Windstream Holdings, Inc. (NASDAQ:WIN) a company that provides communications and technology solutions in the United States is currently up (+0.02%) on 1,366,977 shares traded. Windstream Holdings, Inc. (NASDAQ:WIN) is currently up (+11.73%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Windstream Holdings, Inc. (NASDAQ:WIN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com